2000 Sierra Point Parkway, Suite 1200
Brisbane, CA 94005
Vera was incorporated in May 2016 in Delaware.
Vera Therapeutics went public on the Nasdaq exchange on 05/13/2021 at $11/share.
Our fiscal year end is December 31.
Vera is listed under the NASDAQ Global Market under the ticker symbol VERA.
Vera does not pay cash dividends on its common stock and does not anticipate doing so in the foreseeable future.
Communication regarding transfer requirements, lost certificates and changes of address should be directed to: American Stock Transfer & Trust Company, LLC (AST). www.astfinancial.com
Vera does not offer a direct purchase plan for investors. You may purchase Vera’s stock through a licensed securities broker.
Press releases, quarterly and annual reports, proxy statements as well as other SEC filings, can be accessed in the Financial Information section of our Investors & Media webpage. SEC filings may also be obtained directly from the SEC at www.sec.gov.
Email queries may be sent to https://ir.veratx.com/investor-resources/contact-ir